Dipan J Shah

Dipan J Shah is an expert in Cardiology at Houston Methodist (United States). As of October 2026, ScienceLeadR ranks Dipan J Shah in the top 1% of experts worldwide for Mitral Valve Insufficiency and Aortic Valve Disease. Dipan J Shah has authored 401 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 1,550 (community average: 125). How the SLR is computed.

Cardiology

Subspecialties: Medical Imaging - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 19, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2009 - 2026

Source: PubMed

Weill Cornell Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 401

Citations

Citations: 10 182 1st author: 12 Last author: 136 Unique author: 8

Main journals

J Am Coll Cardiol 76

J Cardiovasc Magn Reson 46

JACC Cardiovasc Imaging 46

Methodist Debakey Cardiovasc J 33

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
Assessment of Severity of Chronic Aortic Regurgitation: Importance of a Hierarchical Approach to Echocardiogram Doppler Parameters. PMID 42886151 — aortic valve insufficiency	JACC Cardiovasc Imaging	2026	0
Optimizing Echocardiographic Evaluation of Chronic Mitral Regurgitation: Comparison With Cardiac Magnetic Resonance Imaging and Implications for Guideline Recommendations. PMID 42886153 — pulmonary veins, mitral valve, magnetic resonance imaging, echocardiography, mitral valve insufficiency, veins	JACC Cardiovasc Imaging	2026	0
Circulating Biomarkers Related to Mitral Valve Prolapse: Current Evidence and Mechanistic Perspective. PMID 42700327 — heart diseases, mitral valve, fibrosis, biomarkers, mitral valve prolapse, prolapse	Curr Cardiol Rep	2026	0
Stress Perfusion CMR to Prognosticate for Left Main and High Risk Multivessel Coronary Artery Disease and Major Cardiovascular Adverse Events: Outcomes From a 4,144-Patient Multicenter Cohort. PMID 42622598 — myocardial ischemia, mortality, coronary artery disease, stress, physiological, diagnostic techniques, cardiovascular, arteries, drug-related side effects and adverse reactions, diagnosis, ischemia, prognosis	JACC Cardiovasc Imaging	2026	1
Comparative risk of hepatocellular carcinoma and mortality among initiators of GLP-1 receptor agonists versus other glucose-lowering therapies: a target trial emulation. PMID 42584814 — liver diseases, glucagon-like peptide 1, mortality, carcinoma, hepatocellular, glucagon-like peptide-1 receptor, insulin, probability, diagnosis, therapeutics, metformin	Hepatol Int	2026	0

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 5

Phase 3 1

By status:

Completed 4

Recruiting 2

By type:

Observational 5

Interventional 1

By Monocentric/Multicentric:

monocentric 1

multicentric2to4 2

multicentric5to9 0

multicentricup10 3

Main Topics

Cardiovascular Diseases 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno occlusive Disease in Adult Patients With Suspected Vascular Disease NCT07348640 — magnetic resonance angiography, meglumine, safety, cross-over studies, multiple chronic conditions, angiography, vascular diseases	Phase 3	Recruiting	2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice